Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun medicine A particular
antidiabetic drug
Etymologies
Sorry, no etymologies found.
Support
![](/assets/logo-heart.png)
Help support Wordnik (and make this page ad-free) by adopting the word vildagliptin.
Examples
-
Incidence of serious adverse events, including hypoglycemia was low, and vildagliptin was generally demonstrated to be well-tolerated12.
-
The single-pill combination Eucreas/Galvus vildagliptin and metformin contributed 65% of total sales, growing 48% over the third quarter of 2010.
-
Galvus Group USD 181 million, +65% cc, which comprises oral treatments containing vildagliptin for type 2 diabetes, continued to deliver strong growth, driven partly by Japan, where the two-week prescription restriction was lifted.
-
Approval was based on a 24-week, double-blind, randomized, parallel-group study which compared the effects of vildagliptin versus placebo in Chinese patients with type 2 diabetes already receiving metformin n=43812.
-
Japan's Ministry of Health, Labour and Welfare has approved Equa (vildagliptin), marketed as Galvus in the European Union, for the treatment of type 2 diabetes, Exforge
-
Japan's Ministry of Health, Labour and Welfare has approved Equa (vildagliptin), marketed as Galvus in the European Union, for the treatment of type 2 diabetes, Exforge
-
In a span of two years, and with two products like Januvia (sitagliptin by Merck & Co) and Galvus (vildagliptin by Novartis) in the market, this class of drugs has already achieved annual global sales of $1.5 billion.
-
In a span of two years, and with two products like Januvia (sitagliptin by Merck & Co) and Galvus (vildagliptin by Novartis) in the market, this class of drugs has already achieved annual global sales of $1.5 billion.
-
The latter problem led to the FDA issuing only an approvable letter for Novartis 'DPP-4 drug Galvus (vildagliptin) a couple of years ago.
-
In a span of two years, and with two products like Januvia (sitagliptin by Merck & Co) and Galvus (vildagliptin by Novartis) in the market, this class of drugs has already achieved annual global sales of $1.5 billion.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.